Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kim, Minsoo ^a   Yoon, Soomin ^a   Lee, Sukmook ^b   Ha, Seon Ah ^c   Kim, Hyun Kee ^c   Kim, Jin Woo ^c   Chung, Junho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Scripps Korea Antibody Institute   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GREMLIN 1 PROTEIN; MONOCLONAL ANTIBODY; OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN; CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR CELL; CELL MOTION; DRUG EFFECT; METABOLISM; TUMOR CELL LINE;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84859726666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035100     Document Type: Article

References (27)

1. Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, et al. (1997) Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol 17: 4801-4810.
2. Topol LZ, Modi WS, Koochekpour S, Blair DG, (2000) DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain. Cytogenet Cell Genet 89: 79-84.
3. Topol LZ, Bardot B, Zhang Q, Resau J, Huillard E, et al. (2000) Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 275: 8785-8793.
4. Stanley E, Biben C, Kotecha S, Fabri L, Tajbakhsh S, et al. (1998) DAN is a secreted glycoprotein related to Xenopus cerberus. Mech Dev 77: 173-184.
5. Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN, et al. (1999) The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 126: 5515-5522.
6. Lappin DW, Hensey C, McMahon R, Godson C, Brady HR, (2000) Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens 9: 469-472.
7. Lu MM, Yang H, Zhang L, Shu W, Blair DG, et al. (2001) The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev Dyn 222: 667-680.
8. Shi W, Zhao J, Anderson KD, Warburton D, (2001) Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol 280: L1030-1039.
9. Sun J, Zhuang FF, Mullersman JE, Chen H, Robertson EJ, et al. (2006) BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction. J Biol Chem 281: 29349-29356.
10. Chen B, Blair DG, Plisov S, Vasiliev G, Perantoni AO, et al. (2004) Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis. J Immunol 173: 5914-5917.
11. Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, et al. (2010) Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 116: 3677-3680.
12. Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, et al. (2006) The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6: 74.
13. Sha G, Zhang Y, Zhang C, Wan Y, Zhao Z, et al. (2009) Elevated levels of gremlin-1 in eutopic endometrium and peripheral serum in patients with endometriosis. Fertil Steril 91: 350-358.
14. Lee MS, Lee JC, Choi CY, Chung J, (2008) Production and characterization of monoclonal antibody to botulinum neurotoxin type B light chain by phage display. Hybridoma (Larchmt) 27: 18-24.
15. Park S, Lee DH, Park JG, Lee YT, Chung J, (2010) A sensitive enzyme immunoassay for measuring cotinine in passive smokers. Clin Chim Acta 411: 1238-1242.
16. Kim K, Hur Y, Ryu EK, Rhim JH, Choi CY, et al. (2007) A neutralizable epitope is induced on HGF upon its interaction with its receptor cMet. Biochem Biophys Res Commun 354: 115-121.
17. Chung J, Rader C, Popkov M, Hur YM, Kim HK, et al. (2004) Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation. FASEB J 18: 361-363.
18. Li XL, Wang CZ, Mehendale SR, Sun S, Wang Q, et al. (2009) Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemother Pharmacol 64: 1097-1104.
19. Rosso O, Piazza T, Bongarzone I, Rossello A, Mezzanzanica D, et al. (2007) The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Mol Cancer Res 5: 1246-1253.
20. Tomayko MM, Reynolds CP, (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148-154.
21. Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, et al. (2006) Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A 103: 14842-14847.
22. Singh A, Morris RJ, (2010) The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev 21: 299-313.
23. Chen D, Zhao M, Mundy GR, (2004) Bone morphogenetic proteins. Growth Factors 22: 233-241.
24. Bobinac D, Maric I, Zoricic S, Spanjol J, Dordevic G, et al. (2005) Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 46: 389-396.
25. Gupta GP, Massague J, (2006) Cancer metastasis: building a framework. Cell 127: 679-695.
26. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G, (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
27. Koli K, Myllarniemi M, Vuorinen K, Salmenkivi K, Ryynanen MJ, et al. (2006) Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 169: 61-71.